White Paper: Physician Access and Appointment Requirements

Published by SK&A, A Cegedim Company

Nearly half of U.S. physicians say they require or prefer appointments to be made by pharmaceutical sales reps prior to one-on-one meetings or details, while about 23 percent of doctors refuse to see reps at any time at any of their practice locations, according to this updated survey by SK&A, A Cegedim Company. Use this report to identify see and no-see prescribers, improve engagement tactics, honor preferences and connect more successfully.

Click Here to Download the White Paper


HOT TOPICS
Wireless Patients
First it was phones, then it was computers, next it could be patients themselves going wireless. Well, at least the monitoring of patients. Healthcare providers want the Federal Communications Commission (FCC) to approve their plan for setting aside bandwidth for mobile body area network technology (MBAN), which could be used to create a wireless body sensor network for monitoring patients via disposable, wireless devices…
Uncovering Alzheimer's
Two recent studies may help researchers better determine if patients have Alzheimer's disease while they are still alive. One used a chemical dye called florbetapir; it binds to the beta-amyloid protein that makes up the plaque found in the brain associated with Alzheimer's and allows it to show up during PET scans.
AH-CHOO!
Allergy sufferers looking to avoid the two-packs-of-pocket-tissues-a-day sneezing, the overblown I-turned-into-Rudolph red nose, and the so-itchy-I-want-to-rip-them-out-of-their-sockets watery eyes can be extra prepared when facing their powdery yellow nemesis this pollen season—thanks to the collaboration between Pollen.com and Weather Trends International.
FDA UPDATE
The FDA proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices as part of its Medical Device Innovation Initiative; is warning women with breast implants of a possible ALCL association, and more


To Access ALL of PM360's Experts on Call Click Here!

FEATURES
PM360 COVER STORY: The Ride Is About to Get Bumpy
By Robert Ward And Michael Wise
With biosimilars, the competitive forces shaping the global biologic brand markets reflect the traditional effects of the launch of a low-cost product. To assess the competitive landscape, marketers can evaluate four key domains of biologic differentiation: Construct, Delivery, Price, and Use.
TECH UPDATE: Boosting Sales and ROI with the Right Tech Tools
By Rob D’urso And John Riggle
Find the right product for your organization and needs. Don’t let being “cool” outweigh being “focused” when it comes to selecting new technologies. Here’s how.
BRAND NAMES: It All Begins With A Name
By Peter L. Tobar
Developing a brand name is a critical responsibility that has the potential to create a lasting imprint on the minds of customers. It is imperative that it be among the first commercial activities initiated in building a brand.
TRENDSETTERS: Ken Makovsky, President of Makovsky + Company
By Jon Brulloths
Makovsky discusses the "rebooting" of the entire healthcare industry.
THE PM360 DIGITAL COMPENDIUM
Editor's Note
By Andrew Matthius
Social Media
Who's Tweeting: The Relation Between Tweets and Balance Sheets
By Joey Barnes
Digital Glossary
Interactive Lingo
By Bruce Lacey and Andrew Matthius
THINK TANK
Experts Discuss How The Digital World Is Reshaping Healthcare
Case Study
Developing a Path to Digital Success
By Hans Wernke
Online Metrics
Measuring Behavior Online: It's More Than Just Clicks
By Ben Curtis
Company Snapshots
Directory of Companies That Are Changing the Landscape of Healthcare
Digital World View
5 Statistics That Could Change the Way You Work
By Leigh Householder
INDEX of Company Snapshots




IN THIS ISSUE
Publisher’s Letter Ahead of the Curve
Guest Commentary How to Fix Flat Results Dave Duplay
Common Sense An I'm OK, You're OK Approach… Bud Bilanich
E-Source The Closed Loop Has a Leak David Ormesher
Marketing Insider Orphan, Ultra, or…Small Market? E.M. (Mick) Kolassa, PhD
Consumer Healthcare Trends Chris DeAngelis NEW COLUMN!
DTC 360 Doing Nothing Is Not an Option Richard Meyer
DTC TALK Lilly's Doug Wilson on Reaching Consumers Richard Meyer
Total Patient Experience Evidence for Demonstrating a Drug's Value Gregory Hess, MD, MBA, MSc
Market Drill-Down Medicare Patients Adopt New Sense of Frugality Paula Fullman
Managed Markets AccessWhy Access Is No Longer Just About "Tier" Susan Weber and Bob Shewbrooks
Optimizing Brand Performance It's Still All About the Message Les Leathem
Healthcare Highlights FDA Update and more
Industry Briefs ResearchShare app, and more
Life Style betterworldbooks.com, and more
Cutting Edge Gadgets and gear for today's on-the-go professional
Movers & Shakers Career changes in the industry
Calendar A quick reference list of upcoming industry events
PhotoFinish A Night on Times Square


2011 Editorial Calendar Now Available!

Click Here to Download



Site ©2008-2011 AMS Group LLC.

blog comments powered by Disqus